Susquehanna International Group, LLP Provention Bio, Inc. Call Options Transaction History

Susquehanna International Group, LLP

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 16, 2023	SELL	$6.7 - $24.21 $1.36 Million - $4.93 Million	-203,600 Reduced 37.77%	335,500 $8.09 Million
Q4 2022 Feb 14, 2023	BUY	$4.52 - $10.57 $1.81 Million - $4.24 Million	400,800 Added 289.8%	539,100 $5.7 Million
Q3 2022 Nov 14, 2022	BUY	$3.43 - $5.62 $61,740 - $101,160	18,000 Added 14.96%	138,300 $622,000
Q2 2022 Aug 15, 2022	SELL	$3.65 - $7.3 $192,355 - $384,710	-52,700 Reduced 30.46%	120,300 $481,000
Q1 2022 May 16, 2022	SELL	$3.4 - $7.88 $330,480 - $765,936	-97,200 Reduced 35.97%	173,000 $1.27 Million
Q3 2021 Nov 15, 2021	BUY	$5.66 - $8.33 $1.12 Million - $1.65 Million	198,500 Added 276.85%	270,200 $1.73 Million
Q2 2021 Aug 11, 2021	SELL	$6.71 - $11.04 $375,089 - $617,136	-55,900 Reduced 43.81%	71,700 $604,000
Q1 2021 May 17, 2021	SELL	$10.12 - $19.45 $219,603 - $422,065	-21,700 Reduced 14.53%	127,600 $1.34 Million
Q3 2020 Nov 16, 2020	SELL	$10.34 - $15.2 $1.78 Million - $2.62 Million	-172,100 Reduced 53.55%	149,300 $1.92 Million
Q2 2020 Aug 14, 2020	BUY	$7.81 - $17.0 $2.24 Million - $4.87 Million	286,300 Added 815.67%	321,400 $4.54 Million
Q1 2020 May 15, 2020	SELL	$5.42 - $17.75 $26,558 - $86,975	-4,900 Reduced 12.25%	35,100 $323,000
Q4 2019 Feb 14, 2020	BUY	$5.84 - $14.9 $151,256 - $385,910	25,900 Added 183.69%	40,000 $596,000
Q3 2019 Nov 14, 2019	BUY	$6.83 - $13.0 $96,303 - $183,300	14,100 New	14,100 $96,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.